Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Veterinary Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.0% during the forecast period.
This report presents the market size and development trends by detailing the Veterinary Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Veterinary Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Veterinary Drugs industry and will help you to build a panoramic view of the industrial development.
Veterinary Drugs Market, By Type:
Injury Medicine
Disorder Medicine
Diagnosis Medicine
Others
Veterinary Drugs Market, By Application:
Veterinary Clinics
Veterinary Hospitals
Research Institutions
Others
Some of the leading players are as follows:
Nutreco N.V.
Zoetis, Inc. (Pfizer)
Vetoquinol
Sanofi S.A. (MERIAL Limited).
Virbac
Cargill Inc (Provimi)
Zoetis, Inc (Pfizer)
Cargill Inc. (Provimi)
Ceva Sant Animale
Koninklijke DSM NV
Merck Animal Health
Koninklijke DSM N.V
Boehringer Ingelheim GmbH
Sanofi SA (MERIAL Limited)
Dechra Pharmaceuticals PLC.
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Veterinary Drugs Market: Technology Type Analysis
-
4.1 Veterinary Drugs Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Veterinary Drugs Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Injury Medicine
4.3.2 Disorder Medicine
4.3.3 Diagnosis Medicine
4.3.4 Others
5 Veterinary Drugs Market: Product Analysis
-
5.1 Veterinary Drugs Product Market Share Analysis, 2018 & 2026
-
5.2 Veterinary Drugs Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Veterinary Drugs Market: Application Analysis
-
6.1 Veterinary Drugs Application Market Share Analysis, 2018 & 2026
-
6.2 Veterinary Drugs Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Veterinary Clinics
6.3.2 Veterinary Hospitals
6.3.3 Research Institutions
6.3.4 Others
7 Veterinary Drugs Market: Regional Analysis
-
7.1 Veterinary Drugs Regional Market Share Analysis, 2018 & 2026
-
7.2 Veterinary Drugs Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Nutreco N.V.
9.1.1 Nutreco N.V. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Zoetis, Inc. (Pfizer)
9.2.1 Zoetis, Inc. (Pfizer) Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Vetoquinol
9.3.1 Vetoquinol Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Sanofi S.A. (MERIAL Limited).
9.4.1 Sanofi S.A. (MERIAL Limited). Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Virbac
9.5.1 Virbac Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Cargill Inc (Provimi)
9.6.1 Cargill Inc (Provimi) Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Zoetis, Inc (Pfizer)
9.7.1 Zoetis, Inc (Pfizer) Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Cargill Inc. (Provimi)
9.8.1 Cargill Inc. (Provimi) Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Ceva Sant Animale
9.9.1 Ceva Sant Animale Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Koninklijke DSM NV
9.10.1 Koninklijke DSM NV Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Merck Animal Health
9.11.1 Merck Animal Health Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Koninklijke DSM N.V
9.12.1 Koninklijke DSM N.V Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Boehringer Ingelheim GmbH
9.13.1 Boehringer Ingelheim GmbH Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Sanofi SA (MERIAL Limited)
9.14.1 Sanofi SA (MERIAL Limited) Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Dechra Pharmaceuticals PLC.
9.15.1 Dechra Pharmaceuticals PLC. Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
The List of Tables and Figures (Totals 106 Figures and 133 Tables)
Figure Injury Medicine Veterinary Drugs market, 2015 - 2026 (USD Million)
Figure Disorder Medicine Veterinary Drugs market, 2015 - 2026 (USD Million)
Figure Diagnosis Medicine Veterinary Drugs market, 2015 - 2026 (USD Million)
Figure Others Veterinary Drugs market, 2015 - 2026 (USD Million)
Figure Veterinary Clinics market, 2015 - 2026 (USD Million)
Figure Veterinary Hospitals market, 2015 - 2026 (USD Million)
Figure Research Institutions market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Veterinary Drugs market, by country, 2015 - 2026 (USD Million)
-
Table North America Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table North America Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table North America Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Canada Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Canada Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Europe Veterinary Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Europe Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Europe Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Europe Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Germany Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Germany Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table France Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table France Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Italy Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Italy Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Spain Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Spain Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Veterinary Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table China Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table China Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Japan Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Japan Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table India Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table India Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Veterinary Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table MEA Veterinary Drugs market, by country, 2015 - 2026 (USD Million)
-
Table MEA Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table MEA Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table MEA Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Veterinary Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Veterinary Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Veterinary Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Nutreco N.V. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Zoetis, Inc. (Pfizer) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Vetoquinol Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi S.A. (MERIAL Limited). Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Virbac Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cargill Inc (Provimi) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Zoetis, Inc (Pfizer) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cargill Inc. (Provimi) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ceva Sant Animale Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Koninklijke DSM NV Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck Animal Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Koninklijke DSM N.V Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boehringer Ingelheim GmbH Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi SA (MERIAL Limited) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Dechra Pharmaceuticals PLC. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
